|

[212Pb]VMT-α-NET Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Perspective Therapeutics1

Indications

  • Bronchial Neuroendocrine Tumor1
  • Neuroendocrine Tumor Metastatic1
  • Neuroendocrine Tumors Unresectable1
  • Gastroenteropancreatic Neuroendocrine Tumor1
  • Paraganglioma1

Jacksonville, Florida1 trial

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors

Mayo Clinic

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.